Last reviewed · How we verify
Single dose of methadone
At a glance
| Generic name | Single dose of methadone |
|---|---|
| Sponsor | Wake Forest University Health Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Methadone Pharmacokinetics in Cardiac Surgery (PHASE4)
- A RCT Using Methadone in the Management of Post-Operative Pain in Total Knee Replacement (PHASE4)
- Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder (PHASE2)
- Interaction of CYP2B6 Genotype and Efavirenz With Methadone and Tizanidine PK (EARLY_PHASE1)
- Divided or Single Exposure (DOSE) Study (PHASE2, PHASE3)
- Psilocybin for Opioid Use Disorder (OUD) (PHASE2)
- Combined THC and CBD for OUD and Chronic Pain (PHASE2)
- The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription. (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Single dose of methadone CI brief — competitive landscape report
- Single dose of methadone updates RSS · CI watch RSS
- Wake Forest University Health Sciences portfolio CI